BioCentury
ARTICLE | Company News

Debiopharm, Solid Biosciences deal

October 12, 2015 7:00 AM UTC

The companies partnered to conduct preclinical studies of Debiopharm’s alisporivir ( Debio 025) to treat Duchenne muscular dystrophy (DMD). Debiopharm will fund the studies of the oligopeptide cyclop...